According to Viatris's latest financial reports and stock price the company's current Operating Margin is 17.29%. At the end of 2022 the company had an Operating Margin of 17.30%.
Year | Operating Margin | Change |
---|---|---|
2022 | 17.30% | -565.69% |
2021 | -3.71% | -38.47% |
2020 | -6.04% | -549.68% |
2019 | 1.34% | -48.56% |
2018 | 2.61% | -65.59% |
2017 | 7.58% | 590.22% |
2016 | 1.10% | -88.68% |
2015 | 9.71% | -23.1% |
2014 | 12.62% | 16.71% |
2013 | 10.82% | -8.58% |
2012 | 11.83% | 10.79% |
2011 | 10.68% | 63.53% |
2010 | 6.53% | 46.53% |
2009 | 4.46% | -578.79% |
2008 | -0.93% | -103.53% |
2007 | 26.40% | 20.86% |
2006 | 21.84% | -12.32% |
2005 | 24.91% | -33.19% |
2004 | 37.29% | 10.97% |
2003 | 33.61% | -9.14% |
2002 | 36.98% | 439.78% |
2001 | 6.85% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -36.36% | -310.29% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -8,391.15% | -48,631.81% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.